← Back to the wire

Amgen Raises Full-Year Outlook By $1 Billion After Strong Q2 Sales

Guidance·2 articles across 2 outlets

Story updated Rewritten when the story materially grows; the wire is checked every 15 minutesAbout this data

Amgen Inc. raised its full-year profit and revenue forecast after the drugmaker beat Wall Street’s expectations in sales of its key medicines.

Amgen smashed Wall Street's second-quarter expectations late Tuesday, delivering double-digit sales growth for nearly two dozen products.

Amgen

Sources

Every quote below is verbatim from the article it is attributed to.

SourceReports the news
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.